Back to results
UnknownPhase 4

Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID)

NCT01515774

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Seoul National University Hospital

Seoul, South Korea

Contact

Beom S Jeon, MD, PhD

82-2-2072-2876brain@snu.ac.kr
View on ClinicalTrials.gov
Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID) — TrialFind